ARCHIVES

Feds Set Guidelines For Pharma To Help Patients With Cost Of Drugs, While Steering Clear Of Anti-Kickback Law.

This article is from The Cancer Letter archive.

Vol. 32 No. 16 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

July 28, 1995

Klausner To Serve As Advisor On Bioterrorism For NAS.

January 4, 2002

Yates Identifies “Probable”, “Potential” Core Grant Applicants

January 16, 1987

The President’s Cancer Panel publishes its annual report

May 6, 2011

Fluoride Study Update Finds No Increased Risk

October 19, 1990

Clinical Trials Approved Last Month By NCI’s CTEP

May 31, 2002